HEAT-TREATMENT OF LEUKEMIC-CELL LINES CAN INCREASE THEIR SENSITIVITY TO NK LYSIS

被引:4
|
作者
SCOTT, JE [1 ]
DAWSON, JR [1 ]
机构
[1] DUKE UNIV,MED CTR,DEPT IMMUNOL,DURHAM,NC 27710
关键词
D O I
10.1006/cimm.1995.1129
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The effect of stress on target cell susceptibility to human natural killer cell-mediated lysis was examined. Targets were incubated at 37, 42, or 45 degrees C for 1 hr and then tested for NK sensitivity in chromium-release assays, The T cell target JURKAT displayed minor increases in susceptibility to NK lysis with 42 degrees C pretreatment (20-50% increases) and dramatic increases in lysability with 45 degrees C pretreatment (100-300% increase) compared to control, In contrast, lysis of the NK prototypic target K562 is not increased after 42 or 45 degrees C pretreatment, Kinetic studies indicated an optimal NK sensitivity enhancement time of 1 hr at 45 degrees C for JURKAT. Inhibition of target cell protein synthesis by emetine pretreatment does not produce an increase in susceptibility to NK lysis, JURKAT cells pretreated with sodium arsenite exhibited a comparable increase in NK sensitivity to the heat treatments, Cold target inhibition assays suggest that the increase in sensitivity after heat treatment is at a postbinding stage, This was exemplified by the increased sensitivity of JURKAT, but not K562, to lysis mediated by isolated rat NK granules, These results indicate that a heat-sensitive, de novo protein synthesis-independent defense mechanism against lysis may exist in some tumors, altering their susceptibility to lysis by NK cells. (C) 1995 Academic Press, Inc.
引用
收藏
页码:296 / 302
页数:7
相关论文
共 50 条
  • [1] DIFFERENTIAL SENSITIVITY OF LEUKEMIC-CELL LINES TO NITROBENZYLTHIOINOSINE
    CASS, CE
    PETEYA, DJ
    LYNCH, MA
    TUPAS, J
    JANMOHAMED, N
    JANOWSKAWIECZOREK, A
    [J]. BONE MARROW TRANSPLANTATION, 1987, 2 : 124 - 124
  • [2] Increased sensitivity of chemoresistant leukemic cells to NK cell lysis
    Ogbomo, H.
    Michaelis, M.
    Doerr, H. W.
    Cinatl, Jr J.
    [J]. KLINISCHE PADIATRIE, 2007, 219 (03): : 190 - 190
  • [3] BINDING OF LECTINS TO LEUKEMIC-CELL LINES
    SCHWENK, HU
    SCHNEIDER, U
    HERZOG, KH
    [J]. BLUT, 1980, 40 (01): : 7 - 15
  • [4] COLLATERAL SENSITIVITY OF HUMAN MULTIDRUG RESISTANT (MDR) LEUKEMIC-CELL LINES TO VERAPAMIL
    BECK, WT
    CIRTAIN, MC
    WOLVERTON, JS
    SAFA, AR
    FELSTED, RL
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 307 - 307
  • [5] THE ROLE OF CALCIUM IN DIFFERENTIATION OF LEUKEMIC-CELL LINES
    REPHAELI, A
    AVIRAM, A
    RABIZADEH, E
    ENGLENDER, T
    SHAKLAI, M
    [J]. CANCER BIOCHEMISTRY BIOPHYSICS, 1990, 11 (02): : 119 - 125
  • [6] SYNTHESIS OF TISSUE FACTOR IN LEUKEMIC-CELL LINES
    SATO, N
    TAKAHASHI, H
    KISHI, K
    SHIBATA, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1182 - 1182
  • [7] PHENOTYPIC CHARACTERISTICS OF RAT LEUKEMIC-CELL LINES
    GREINER, D
    BARTON, R
    REYNOLDS, C
    GOLDSCHNEIDER, I
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 324 - 324
  • [8] LEUKEMIC-CELL LYSIS PNEUMONOPATHY - A COMPLICATION OF TREATED BLAST CRISIS
    TRYKA, AF
    GODLESKI, JJ
    [J]. LABORATORY INVESTIGATION, 1981, 44 (01) : A68 - A68
  • [9] MECHANISM OF LEUKEMIC-CELL LYSIS BY ACTIVATED HUMAN MACROPHAGES - LEUKEMIC-CELLS CAN BY LYSED WITHOUT DIRECT-CONTACT
    NAKABO, Y
    HARAKAWA, N
    YAMAMOTO, K
    OKUMA, M
    UNO, K
    SASADA, M
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 1994, 60 (01) : 51 - 57
  • [10] EXPRESSION OF THE SERGLYCIN GENE IN HUMAN LEUKEMIC-CELL LINES
    MAILLET, P
    ALLIEL, PM
    MITJAVILA, MT
    PERIN, JP
    JOLLES, P
    BONNET, F
    [J]. LEUKEMIA, 1992, 6 (11) : 1143 - 1147